Savara Inc.
USD5.25
+0.00 (+0.00%)
CEO
Matthew Pauls
IPO Date
2017-04-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.29
Prev. Close
$5.25
Day Low
$5.12
Day High
$5.41
52W Low
$1.98
52W High
$7.00
Market Cap
$1.08B
Volume
1.79M
| 24,174 |
| $5.04 |
| 20 Mar 2026 | Lowrance David L | Chief Financial Officer | M-Exempt | Acquired | 75,000 | $1.59 |
| 20 Mar 2026 | Lowrance David L | Chief Financial Officer | F-InKind | Disposed | 23,661 | $5.04 |
| 20 Mar 2026 | Lowrance David L | Chief Financial Officer | M-Exempt | Acquired | 130,650 | $1.23 |
| 20 Mar 2026 | Lowrance David L | Chief Financial Officer | F-InKind | Disposed | 31,885 | $5.04 |
| 20 Mar 2026 | Lowrance David L | Chief Financial Officer | M-Exempt | Acquired | 43,063 | $1.11 |
| 20 Mar 2026 | Lowrance David L | Chief Financial Officer | F-InKind | Disposed | 9,485 | $5.04 |
| 20 Mar 2026 | Lowrance David L | Chief Financial Officer | M-Exempt | Acquired | 12,500 | $4.45 |
| 20 Mar 2026 | Lowrance David L | Chief Financial Officer | F-InKind | Disposed | 11,037 | $5.04 |